Archean Chemical Industries Ltd. AI Stock Analysis
Want to see IN:ACI full AI Analyst Report?
Archean Chemical Industries Ltd. (ACI) AI Stock Analysis
Archean Chemical Industries Ltd.
(NSE:ACI)
The overall score is low, driven primarily by a significant deterioration in financial performance, particularly the negative free cash flow and declining profitability, which raises concerns about the company's operational health. This is compounded by a persistently bearish technical trend and a stretched valuation that does not reflect the current earnings trajectory.
Archean Chemical Industries Ltd. (ACI) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 53.86B
- Dividend Yield
- 0.57%
- Average Volume (3M)
- 112.21K
- Price to Earnings (P/E)
- 53.7
- Beta (1Y)
- 0.33
- Revenue Growth
- 5.99%
- EPS Growth
- -41.58%
- Country
- India
- Employees
- 257
- Sector
- Basic Materials
- Sector Strength
- 61
- Industry
- Chemicals
Archean Chemical Industries Ltd. Business Overview & Revenue Model
Company Description
Archean Chemical Industries Limited operates as a manufacturer and global distributor of specialized chemicals extracted from marine sources, serving markets both within India and worldwide. Its product portfolio prominently features bromine, an esse...
How the Company Makes Money
ACI makes money primarily by manufacturing and selling (1) bromine, (2) bromine derivatives (specialty chemicals made using bromine as a key input), and (3) industrial salt. Revenue is generated through supply contracts and purchase orders with indus...
Archean Chemical Industries Ltd. Financial Statement Overview
Summary
Financial performance is mixed. The balance sheet is strong with low leverage (D/E 0.24) and a solid equity base, but this is offset by a sharp decline in revenue, compressed margins, and critically weak cash flows that have turned negative. The overall financial health is under pressure from deteriorating operations.
Income Statement
45NeutralBalance Sheet
75PositiveCash Flow
25Negative| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.80B | 10.81B | 10.41B | 13.30B | 14.40B | 11.30B |
| Gross Profit | 9.61B | 7.20B | 10.49B | 12.16B | 14.37B | 8.50B |
| EBITDA | 2.52B | 2.47B | 3.11B | 5.06B | 6.77B | 4.79B |
| Net Income | 997.96M | 1.07B | 1.62B | 3.19B | 3.83B | 1.88B |
Balance Sheet | ||||||
| Total Assets | 28.27B | 26.65B | 23.93B | 20.56B | 17.55B | 15.31B |
| Cash, Cash Equivalents and Short-Term Investments | 703.85M | 610.77M | 2.55B | 3.95B | 2.31B | 695.11M |
| Total Debt | 5.51B | 4.66B | 2.35B | 978.23M | 693.85M | 9.00B |
| Total Liabilities | 8.67B | 7.32B | 5.29B | 3.54B | 3.24B | 12.69B |
| Stockholders Equity | 19.63B | 19.34B | 18.64B | 17.02B | 14.31B | 2.62B |
Cash Flow | ||||||
| Free Cash Flow | 0 | -2.50B | -873.38M | 1.71B | 3.96B | 2.18B |
| Operating Cash Flow | 0 | 1.32B | 1.76B | 3.79B | 4.96B | 3.15B |
| Investing Cash Flow | 0 | -2.96B | -2.46B | -3.07B | -2.90B | -1.10B |
| Financing Cash Flow | 0 | 1.64B | 649.80M | -325.69M | -2.12B | -2.24B |
Archean Chemical Industries Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ACI, the sentiment is Negative. The current price of 436.15 is below the 20-day moving average (MA) of 444.78, below the 50-day MA of 463.11, and below the 200-day MA of 530.81, indicating a bearish trend. The MACD of -9.08 indicates Negative momentum. The RSI at 43.69 is Neutral, neither overbought nor oversold. The STOCH value of 50.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ACI.
Archean Chemical Industries Ltd. Peers Comparison
Overall Rating
IN:GHCL76Outperform
IN:GNFC71Outperform
IN:DEEPAKNTR56Neutral
IN:GUJALKALI54Neutral
IN:TATACHEM47Neutral
IN:ACI46Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 76Outperform | INR 41.83B | 7.79 | ― | 2.64% | 1.69% | -1.63% | |
| 71Outperform | INR 68.77B | 6.53 | ― | 4.48% | 22.49% | 65.41% | |
| Sector * | 61Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |
| 56Neutral | INR 216.86B | 20.07 | ― | 0.48% | 25.13% | 99.89% | |
| 54Neutral | INR 43.40B | 32.07 | ― | 3.06% | 11.16% | 88398.04% | |
| 47Neutral | INR 165.45B | -6.84 | ― | 1.73% | 4.93% | -1174.55% | |
| 46Neutral | INR 53.85B | 53.69 | ― | 0.57% | 5.99% | -41.58% |
* Basic Materials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:ACI | Archean Chemical Industries Ltd. | 436.15 | -102.01 | -18.96% | |
| IN:DEEPAKNTR | Deepak Nitrite Limited | 1561.25 | -122.76 | -7.29% | |
| IN:GHCL | Ghcl Limited | 454.00 | -126.46 | -21.79% | |
| IN:GNFC | Gujarat Narmada Valley Fertilizers & Chemicals Ltd. | 468.00 | -7.18 | -1.51% | |
| IN:GUJALKALI | Gujarat Alkalies & Chemicals Ltd. | 579.10 | 47.77 | 8.99% | |
| IN:TATACHEM | Tata Chemicals Limited | 634.70 | -162.95 | -20.43% |
Archean Chemical Industries Ltd. Corporate Events
Archean Chemical Releases Q2 and H1 FY27 Investor Presentation
Archean Chemical Industries Limited announced the release of an investor presentation for its earnings call covering the quarter and half year ended September 30, 2026. Submitted to the stock exchanges under applicable SEBI disclosure requirements, t...
Archean Chemical’s Long-Term Bank Facilities See Rating Downgrade as Borrowings Rise
Archean Chemical Industries Ltd. has disclosed that CRISIL has downgraded its rating on the company’s long-term bank facilities, even as the total rated amount has been significantly increased. The long-term facilities have risen from Rs.265 crore to...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 17, 2026
